Search

Your search keyword '"Cadoni, Gabriella"' showing total 347 results

Search Constraints

Start Over You searched for: Author "Cadoni, Gabriella" Remove constraint Author: "Cadoni, Gabriella"
347 results on '"Cadoni, Gabriella"'

Search Results

2. Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE)

3. Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

4. Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach

5. Shared heritability and functional enrichment across six solid cancers.

7. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer

8. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer

9. Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis

10. Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

11. Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium

12. Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium

14. Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium

16. Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium

17. Supplementary Table from Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium

18. Data from Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium

19. The effect of body mass index at cancer diagnosis on survival of patients with squamous cell head and neck carcinoma

20. Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts

21. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents

24. New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report

25. Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium

26. Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study

27. Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium.

28. Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium

29. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer

30. Erratum to: Recreational physical activity and risk of head and neck cancer: a pooled analysis within the international head and neck cancer epidemiology (INHANCE) Consortium

31. Recreational physical activity and risk of head and neck cancer: a pooled analysis within the international head and neck cancer epidemiology (INHANCE) Consortium

32. Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer

33. Postural control and disability in patients with early rheumatoid arthritis

34. Immunohistochemical detection of “ex novo”HLA‐DRin tumor cells determines clinical outcome in laryngeal cancer patients

36. Erratum to “Prognostic Role of Serum Amino Acids in Head and Neck Cancer”

37. Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers

39. Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

40. Germline Determinants of Humoral Immune Response To HPV-16 Protect Against Oropharyngeal Cancer

42. Prognostic Role of Serum Amino Acids in Head and Neck Cancer

43. Immunohistochemical detection of "ex novo" HLA‐DR in tumor cells determines clinical outcome in laryngeal cancer patients.

46. Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE)

47. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

49. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

Catalog

Books, media, physical & digital resources